These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 1097133)

  • 1. Determination of hydroxyproline polypeptides in urine and blood serum by gel filtration.
    Dubovsky J; Meyer RD
    Clin Chim Acta; 1975 Jul; 62(2):277-86. PubMed ID: 1097133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary polypeptides related to collagen synthesis.
    Krane SM; Muñoz AJ; Harris ED
    J Clin Invest; 1970 Apr; 49(4):716-29. PubMed ID: 4315304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abnormal hydroxyproline polypeptides in the urine of patients with chronic uremia.
    Dubovsky J; Meyer RD
    Nephron; 1976; 17(1):20-7. PubMed ID: 934411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymorphism of urinary 4-hydroxyproline-containing polypeptides.
    Szymanowicz A
    J Chromatogr; 1981 Sep; 225(1):55-63. PubMed ID: 7298759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary excretion of glycosaminoglycans and hydroxyproline in Paget's disease of bone, compared with neoplastic invasion of bone.
    Bower L; Manley G
    J Clin Pathol; 1981 Oct; 34(10):1097-101. PubMed ID: 7309892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Collagen-like fragments: excretion in urine of patients with Paget's disease of bone.
    Krane SM; Muñoz AJ; Harris ED
    Science; 1967 Aug; 157(3789):713-6. PubMed ID: 6028049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Modifications of peptide hydroxyprolinuria during Paget's disease and osteoma (author's transl)].
    Dakkak R; Goussault Y; Dreux C
    Ann Biol Clin (Paris); 1979; 37(4):195-200. PubMed ID: 525849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimation of hydroxylysine in urine and serum of patients with chronic uremia.
    Dubovsky J; Geary WT; Chilcutt DA
    Clin Chim Acta; 1977 Apr; 76(1):41-53. PubMed ID: 856503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A column chromatography fractionation of the hydroxyproline-containing urinary peptides with continuous automatic detection.
    Szymanowicz A; Malgras A; Cosson R; Randoux A; Borel JP
    Ann Biol Clin (Paris); 1975; 33(5):351-8. PubMed ID: 1217759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Middle molecules in uremic serum, urine and dialysis fluid.
    Migone L; Dall'taglio P; Buzio C
    Clin Nephrol; 1975; 3(3):82-93. PubMed ID: 1139803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Chromatographic analysis of urinary amino acids in Paget's disease. I : Biochemical study. Isolation and amino acid composition of a urinary peptide specific to this bone disease].
    Fabier JL; Viau M; Constans J; Clerc A
    Rev Rhum Mal Osteoartic; 1976 Apr; 43(4):249-53. PubMed ID: 1273474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical significance of free plasma hydroxyproline measurement in metabolic bone disease.
    Minisola S; Antonelli R; Mazzuoli G
    J Clin Chem Clin Biochem; 1985 Sep; 23(9):515-9. PubMed ID: 4067520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The measurement of urinary amino-terminal telopeptides of type I collagen to monitor bone resorption in patients with primary hyperparathyroidism.
    Minisola S; Pacitti MT; Rosso R; Pellegrino C; Ombricolo E; Pisani D; Romagnoli E; Damiani C; Aliberti G; Scarda A; Mazzuoli SF
    J Endocrinol Invest; 1997 Oct; 20(9):559-65. PubMed ID: 9413811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of serum osteocalcin with total and bone specific alkaline phosphatase and urinary hydroxyproline:creatinine ratio in patients with Paget's disease of bone.
    Kaddam IM; Iqbal SJ; Holland S; Wong M; Manning D
    Ann Clin Biochem; 1994 Jul; 31 ( Pt 4)():327-30. PubMed ID: 7979096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary excretion of hydroxyproline, hydroxylysine and hydroxylysine glycosides by patients with Paget's disease of bone and carcinoma with metastases in bone.
    Kelleher PC
    Clin Chim Acta; 1979 Mar; 92(3):373-9. PubMed ID: 436278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measurement of urinary excretion of nonisomerized and beta-isomerized forms of type I collagen breakdown products to monitor the effects of the bisphosphonate zoledronate in Paget's disease.
    Garnero P; Gineyts E; Schaffer AV; Seaman J; Delmas PD
    Arthritis Rheum; 1998 Feb; 41(2):354-60. PubMed ID: 9485094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Chromatographic analysis of urinary amino acids in Paget's disease. II : clinical study].
    Roques CF; Mazières B; Amigues H; Fournie A; Arlet J; Ruffié R
    Rev Rhum Mal Osteoartic; 1976 Apr; 43(4):255-8. PubMed ID: 1273475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hydroxyproline excretion following renal transplantation: comparison with values found in primary hyperparathyroidism.
    Goulding A; McChesney R; Dixon SR
    N Z Med J; 1977 Jun; 85(590):517-21. PubMed ID: 343003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of gallium to treat Paget's disease of bone: a pilot study.
    Matkovic V; Apseloff G; Shepard DR; Gerber N
    Lancet; 1990 Jan; 335(8681):72-5. PubMed ID: 1967419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.